トルコトップクラスのリンパ腫専門家の一人として、ギュルバシュ教授はアナドル医療センターに骨髄移植センターを設立しました。これまでに900件以上の手術を執刀しています。
Dr. Bülent Karagöz はリンパ腫を専門とし、腫瘍生物学、免疫療法、分子標的療法に注力しています。33年の経験 年にわたる腫瘍学の経験により、高度な医療を提供しています。
スーラスキー医療センターにおけるリンパ腫の第一人者であり、41年の経験以上の専門的な腫瘍学経験を有する。
, India
Dr. K.K. Iswaran is a reputed and experienced Obstetrician and Gynaecologist with more than 25 years of experience in his field. His key takeaways include:
ロン・ラム医師は、内科、血液学、医療腫瘍学の認定医です。彼のプロフェッショナルな旅は、ニューヨーク州立大学ブルックリン校でのレジデンシーと、ニューヨーク医科大学ウェストチェスター医療センターでの血液学と腫瘍学のフェローシップを含みます。医学分野への彼の献身は、30以上の科学論文と医学教科書の1章を含む広範な学術的貢献を通じて示されています。さらに、彼は数百件の幹細胞移植を行い、この分野での彼の専門性を強調しています。
Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children's Hospital. She specializes in bone marrow and umbilical blood transplantation for pediatric patients. Dr. El Hasid has conducted over 300 successful transplantations. This volume of procedures provides her with deep clinical insight into complex hematologic cases.
The doctor treats children with blood disorders and various forms of pediatric cancer. She uses high-precision procedures and therapies to improve patient outcomes. Her clinical focus includes:
Dr. El Hasid treats a wide range of hematologic and oncologic conditions, including:
Dr. El Hasid leads the Department of Pediatric Oncohematology and Oncology at Dana Dwek Children's Hospital. This facility is part of the Sourasky Medical Center (Ichilov) in Tel Aviv. She gained international experience through practice at the City of Hope Hospital in Los Angeles. Additionally, she serves at various medical centers across Israel.
The doctor contributes to the medical community through research and speaking engagements. Her academic record includes:
She stays connected to clinical advancements through several professional organizations:
Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.
Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
Prof. Dr. Ceyhun Bozkurt is a respected Pediatric Hematologist-Oncologist. He is known for his work in childhood blood disorders and cancers. He graduated from Cerrahpaşa Faculty of Medicine. He holds specializations in both Pediatrics and Pediatric Oncology. Since 2019, he has been Professor and Clinical Director at Bahçelievler Medical Park Hospital. He also serves as Vice Director of the Stem Cell Transplant Unit.
Dr. Bozkurt has published over 40 peer-reviewed articles. He is recognized for his work in leukemia, bone marrow transplantation, and stem cell therapy. He is a member of organizations such as SIOP and EBMT. His memberships show his dedication to high standards in clinical care and research.
グラウペラ博士は受賞歴のある小児腫瘍医であり、骨および軟部組織肉腫の名医の一人です。 サンジョアン・デ・デウ病院の血液腫瘍科を率いており、同病院はヨーロッパ屈指の子供病院です。 研究者。 米国で訓練を受けました。
神経芽細胞腫、神経膠腫、ユーイング肉腫、ウィルムス腫瘍の治療を提供します。
ジャウメ・モラ・グラウペラ博士は、子供の悪性腫瘍治療に関する70以上の論文を執筆しています。 放射線療法を用いない脊髄神経膠腫に対する受動的治療法を開発しました。
Children's Hematologist. Specialist in bone marrow transplantation
Dr. Li Ping, M.D., Ph.D., is Chief Physician and Professor in the Department of Hematology at Shanghai Tongji Hospital, Tongji University School of Medicine. She supervises doctoral and master's students and is an expert in hematologic malignancies.
She earned a Doctor of Medical Science from Nagoya University and completed postdoctoral research. She specializes in diagnosing and treating blood cancers. Her focus includes lymphoid malignancies—leukemias, lymphomas, and multiple myeloma. She treats patients with chemotherapy, hematopoietic stem cell transplantation, targeted therapy, and immunotherapy.
She is a pioneer in China in full-cycle CAR-T therapy for relapsed or refractory blood cancers. She leads and participates in national and international clinical trials. She serves on committees of professional societies, including the China Anti-Cancer Association. She also publishes and trains hematologists.
イェシム・イルドゥルム教授は、がん免疫療法や分子標的療法などの高度な治療を専門とする腫瘍内科学の教授です。
カンソイ教授はトルコ初の小児骨髄移植ユニットを設立し、小児リンパ腫および幹細胞治療にキャリアを捧げてきた。
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 49年の経験 | リンパ腫・骨髄移植 | アナドル骨髄移植センターの創設者であり、MDアンダーソンをはじめとする世界有数の施設で研鑽を積んだ。腫瘍血液内科部門を統括し、主要な国際血液学会の会員を務める。 | トルコ | から $280 | |
| #2 | 33年の経験 | リンパ腫免疫療法 | 腫瘍免疫学および分子標的療法を専門とし、がん研究に関する40本以上の論文を発表。主要な教育病院において腫瘍内科部長を歴任。 | トルコ | から $215 | |
| #3 | 41年の経験 | 複雑なリンパ腫症例 | 高度なリンパ腫治療を専門とし、深い研究との連携を持つ。ESMOファカルティメンバーであり、ソウラスキー医療センター腫瘍科部門の前部門長。 | イスラエル | から $950 | |
| #4 | 22年の経験 | がん免疫療法と分子標的治療 | 免疫療法などの先進的治療を専門とし、80本以上の論文を発表、ESMO認定を取得。英国にて腫瘍免疫学のフェローシップを修了。 | トルコ | から $215 | |
| #5 | 48年の経験 | 小児リンパ腫症例 | 小児骨髄移植のパイオニア－トルコ初の移植ユニットを設立。EBMT認定専門医として、幹細胞研究および移植分野においてリーダーシップを発揮。 | トルコ | お問い合わせください |